DONNATAL EXTENTABS SRT 0.0195 MG
SCOPOLAMINE HYDROBROMIDE : 0.0195 MG ATROPINE SULFATE : 0.0582 MG HYOSCYAMINE SULFATE : 0.3111 MG PHENOBARBITAL : 48.6 MG · DIN 02042908 · WYETH-AYERST CANADA INC.
Health Canada status: CANCELLED POST MARKET
What is DONNATAL EXTENTABS SRT?
DONNATAL EXTENTABS SRT 0.0195 MG contains SCOPOLAMINE HYDROBROMIDE : 0.0195 MG ATROPINE SULFATE : 0.0582 MG HYOSCYAMINE SULFATE : 0.3111 MG PHENOBARBITAL : 48.6 MG. It is listed in the Health Canada Drug Product Database under DIN 02042908, held by WYETH-AYERST CANADA INC., supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 07-May-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02042908 |
|---|---|
| Brand name | DONNATAL EXTENTABS SRT |
| Generic / active ingredient | SCOPOLAMINE HYDROBROMIDE : 0.0195 MG ATROPINE SULFATE : 0.0582 MG HYOSCYAMINE SULFATE : 0.3111 MG PHENOBARBITAL : 48.6 MG |
| Manufacturer | WYETH-AYERST CANADA INC. |
| Strength | 0.0195 MG |
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Schedule | CONTROLLED DRUGS (CDSA IV) |
| ATC code | A03ED ANTISPASMODICS IN COMBINATION WITH OTHER DRUGS |
| AHFS class | 12:08.08 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 07-May-2001 |
| Original market date | 1994-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02042908 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2042908 |
| Brand name | DONNATAL EXTENTABS SRT |
| Active ingredient / INN | SCOPOLAMINE HYDROBROMIDE : 0.0195 MG ATROPINE SULFATE : 0.0582 MG HYOSCYAMINE SULFATE : 0.3111 MG PHENOBARBITAL : 48.6 MG |
| ATC code | A03ED |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A03 |
| AHFS class | 12:08.08 |
| Health Canada schedule | CONTROLLED DRUGS (CDSA IV) |
| Biosimilar biologic | No |
| Market authorization holder | WYETH-AYERST CANADA INC. |
Which pack is which?
| Strength on the label | 0.0195 MG |
|---|---|
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code A03ED ANTISPASMODICS IN COMBINATION WITH OTHER DRUGS. 0 of 11 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BABY'S OWN GRIPE WATER | .9 MG / 5 ML | LIQUID | DANNORTH LABORATORIES INC. | CANCELLED POST MARKET | DIN 02021781 |
| BABY'S OWN GRIPE WATER - LIQ | 1.8 MG / 5 ML | LIQUID | BLOCK DRUG COMPANY (CANADA) LTD. | CANCELLED POST MARKET | DIN 02227525 |
| BABYS OWN GRIPE WATER | 3.6 MG / 10 ML | LIQUID | G.T. FULFORD PHARMACEUTICALS | CANCELLED POST MARKET | DIN 00402397 |
| BELLERGAL SPACETABS | 0.6 MG | TABLET (EXTENDED-RELEASE) | PALADIN PHARMA INC. | CANCELLED POST MARKET | DIN 00176141 |
| BELLERGAL TAB | .3 MG | TABLET | SANDOZ CANADA INC | CANCELLED POST MARKET | DIN 00176133 |
| DONNATAL ELIXIR | 0.1037 MG / 5 ML | ELIXIR | AYERST LABORATORIES | CANCELLED POST MARKET | DIN 01909282 |
| DONNATAL ELIXIR | 16.2 MG / 5 ML | ELIXIR | WYETH-AYERST CANADA INC. | CANCELLED POST MARKET | DIN 02042894 |
| DONNATAL EXTENTABS | 48.6 MG | TABLET (EXTENDED-RELEASE) | AYERST LABORATORIES | CANCELLED POST MARKET | DIN 01909274 |
| DONNATAL TAB | 0.0194 MG | TABLET | WYETH-AYERST CANADA INC. | CANCELLED POST MARKET | DIN 02042916 |
| GRIPE WATER | Strength | Liquid | SHOPPERS DRUG MART INC. 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8 | CANCELLED POST MARKET | DIN 00417661 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.